Found: 65
Select item for more details and to access through your institution.
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 1964, doi. 10.3390/cells9091964
- By:
- Publication type:
- Article
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1129513
- By:
- Publication type:
- Article
Polymorphisms of glutathione- S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 12, p. 2739, doi. 10.1002/ijc.22590
- By:
- Publication type:
- Article
SV40 and human brain tumors.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 1, p. 140, doi. 10.1002/ijc.11189
- By:
- Publication type:
- Article
Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 6, p. 740, doi. 10.1002/(SICI)1097-0215(19981209)78:6<740::AID-IJC12>3.0.CO;2-5
- By:
- Publication type:
- Article
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 9, p. 1, doi. 10.1038/s41419-020-02940-w
- By:
- Publication type:
- Article
MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2010, v. 42, n. 3, p. 312, doi. 10.1165/rcmb.2009-0060OC
- By:
- Publication type:
- Article
The Presence of Simian-Virus 40 Sequences in Mesothelioma and Mesothelial Cells Is Associated with High Levels of Vascular Endothelial Growth Factor.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2002, v. 26, n. 2, p. 189, doi. 10.1165/ajrcmb.26.2.4673
- By:
- Publication type:
- Article
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684110
- By:
- Publication type:
- Article
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 4, p. 601
- By:
- Publication type:
- Article
Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13198, doi. 10.3390/ijms222413198
- By:
- Publication type:
- Article
CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8391, doi. 10.3390/ijms22168391
- By:
- Publication type:
- Article
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2738, doi. 10.3390/ijms22052738
- By:
- Publication type:
- Article
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5205, doi. 10.3390/ijms21155205
- By:
- Publication type:
- Article
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 2, p. 429, doi. 10.3390/ijms20020429
- By:
- Publication type:
- Article
Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03400-7
- By:
- Publication type:
- Article
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma.
- Published in:
- Genes, Chromosomes & Cancer, 2000, v. 29, n. 2, p. 173, doi. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1019>3.0.CO;2-B
- By:
- Publication type:
- Article
Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells.
- Published in:
- International Journal of Oncology, 2020, v. 57, n. 3, p. 835, doi. 10.3892/ijo.2020.5089
- By:
- Publication type:
- Article
Malignant Mesothelioma as both a challenge and an opportunity.
- Published in:
- Oncogene, 2004, v. 23, n. 57, p. 9155, doi. 10.1038/sj.onc.1208180
- By:
- Publication type:
- Article
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00089
- By:
- Publication type:
- Article
The Impact of 3D Nichoids and Matrix Stiffness on Primary Malignant Mesothelioma Cells.
- Published in:
- Genes, 2024, v. 15, n. 2, p. 199, doi. 10.3390/genes15020199
- By:
- Publication type:
- Article
The Biochemical Role of the Human NEIL1 and NEIL3 DNA Glycosylases on Model DNA Replication Forks.
- Published in:
- Genes, 2019, v. 10, n. 4, p. 315, doi. 10.3390/genes10040315
- By:
- Publication type:
- Article
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo.
- Published in:
- Biology Direct, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13062-023-00374-w
- By:
- Publication type:
- Article
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 797, doi. 10.1002/1878-0261.13591
- By:
- Publication type:
- Article
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 797, doi. 10.1002/1878-0261.13591
- By:
- Publication type:
- Article
Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1285031
- By:
- Publication type:
- Article
Editorial: Prognostic factors in non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1174625
- By:
- Publication type:
- Article
The function and clinical implication of circular RNAs in lung cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.862602
- By:
- Publication type:
- Article
<i>MSLN</i> Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085935
- By:
- Publication type:
- Article
Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058051
- By:
- Publication type:
- Article
Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036856
- By:
- Publication type:
- Article
Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0014110
- By:
- Publication type:
- Article
Neuro–Immune Interactions in Severe COVID-19 Infection.
- Published in:
- Pathogens, 2022, v. 11, n. 11, p. 1256, doi. 10.3390/pathogens11111256
- By:
- Publication type:
- Article
Is There Already a Need of Reckoning on Cancer Immunotherapy?
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.638279
- By:
- Publication type:
- Article
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
- Published in:
- Stem Cell Research & Therapy, 2017, v. 8, p. 1, doi. 10.1186/s13287-017-0573-7
- By:
- Publication type:
- Article
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 3, p. 316, doi. 10.1007/s11547-023-01602-z
- By:
- Publication type:
- Article
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma.
- Published in:
- International Journal of Biological Markers, 2010, v. 25, n. 3, p. 164, doi. 10.1177/172460081002500307
- By:
- Publication type:
- Article
A Glimpse in the Future of Malignant Mesothelioma Treatment.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.809337
- By:
- Publication type:
- Article
Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00949
- By:
- Publication type:
- Article
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178606
- By:
- Publication type:
- Article
In vitro and in vivo characterization of highly purified human mesothelioma derived cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
In vitro and in vivo characterization of highlypurified Human Mesothelioma derived cells.
- Published in:
- BMC Cancer, 2010, v. 10, p. 54, doi. 10.1186/1471-2407-10-54
- By:
- Publication type:
- Article
Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines.
- Published in:
- Journal of Cellular Physiology, 2002, v. 193, n. 1, p. 37, doi. 10.1002/jcp.10150
- By:
- Publication type:
- Article
Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro.
- Published in:
- Journal of Cellular Physiology, 2000, v. 185, n. 1, p. 126, doi. 10.1002/1097-4652(200010)185:1<126::AID-JCP12>3.0.CO;2-2
- By:
- Publication type:
- Article
PD-1/PD-L1 immunecheckpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.911579
- By:
- Publication type:
- Article
Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.933071
- By:
- Publication type:
- Article
Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.895708
- By:
- Publication type:
- Article